Viracta Therapeutics (VIRX) Stock Chart & Stock Price History $0.02 +0.00 (+1.25%) As of 07/3/2025 12:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viracta Therapeutics Stock Price Performance The Viracta Therapeutics (VIRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 96.63%, with a year-to-date return of -89.93%. In the past month, the stock has decreased 1.22%, reflecting recent market activity. As of the latest close, Viracta Therapeutics traded at $0.02 with a market cap of $644 thousand and volume of 31,733 shares. Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.99%1 Month Performance-1.22%3 Month Performance-26.36%Year-To-Date Performance-89.93%1 Year Performance-96.63% VIRX Stock Chart for Friday, July, 4, 2025 VIRX Chart by TradingView Viracta Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.02$0.02+1.25%$0.02$0.0231,733 shs$644,000.0007/02/2025$0.02$0.02-2.44%$0.02$0.0224,991 shs$636,000.0007/01/2025$0.02$0.02-1.20%$0.02$0.023,593 shs$652,000.0006/30/2025$0.02$0.02-6.74%$0.02$0.02709,325 shs$660,000.0006/27/2025$0.02$0.02+11.95%$0.02$0.0262,817 shs$707,000.0006/26/2025$0.02$0.02-0.62%$0.02$0.02138,039 shs$632,000.0006/25/2025$0.02$0.02+1.91%$0.02$0.0265,792 shs$636,000.0006/24/2025$0.02$0.02-3.09%$0.02$0.0270,796 shs$624,000.0006/23/2025$0.02$0.02+5.88%$0.02$0.01446,860 shs$644,000.0006/20/2025$0.02$0.02$0.02$0.01169,301 shs$608,000.00 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.02$0.02$0.02$0.0230,059 shs$608,000.0006/18/2025$0.02$0.02-11.56%$0.02$0.0230,059 shs$608,000.0006/17/2025$0.02$0.02-6.99%$0.02$0.0243,977 shs$688,000.0006/16/2025$0.02$0.02+6.29%$0.02$0.0260,611 shs$739,000.0006/13/2025$0.02$0.02+4.79%$0.02$0.01109,684 shs$696,000.0006/12/2025$0.02$0.02-10.70%$0.02$0.01430,476 shs$664,000.0006/11/2025$0.02$0.02+10.00%$0.02$0.0252,268 shs$743,000.0006/10/2025$0.02$0.02+9.68%$0.02$0.02244,556 shs$676,000.0006/09/2025$0.02$0.02-8.82%$0.02$0.0281,439 shs$676,000.0006/06/2025$0.02$0.02$0.02$0.0244,350 shs$676,000.0006/05/2025$0.02$0.02+3.66%$0.02$0.02149,334 shs$676,000.0006/04/2025$0.02$0.02+6.49%$0.02$0.0238,381 shs$652,000.0006/03/2025$0.02$0.02$0.02$0.0270,305 shs$612,000.00 Related Companies VRAX Stock Price Chart ADIL Stock Price Chart OGEN Stock Price Chart ENTO Stock Price Chart SLRX Stock Price Chart PTN Stock Price Chart AWH Stock Price Chart ALZN Stock Price Chart PWUP Stock Price Chart ONCO Stock Price Chart Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIRX Stock Alerts